<h1>Data Analysis Report</h1>

<h3>Objective</h3>

<h3>Problem Statement</h3>

<h3>Data & Methodology</h3>

<h3>Key Findings</h3>

  - <b>Business Question Framing:</b> Clearly defines the core business problem of selecting the most financially viable drug line strategy under uncertainty.
  - <b>Decision Tree Methodology:</b> Justifies the use of decision tree analysis due to identifiable decision alternatives, possible states of nature, associated probabilities, and quantifiable payoffs.
  - <b>Data Analysis:</b> Presents relevant data values including profit per unit, favorable and unfavorable demand, success probabilities, and calculated payoffs for each strategic option.
  - <b>Visual Representation:</b> Includes a detailed decision tree diagram illustrating the decision nodes, state-of-nature nodes, payoffs, and expected values for each branch.
  - <b>Expected Value Calculation:</b> Details the step-by-step calculation of expected values for each strategy, demonstrating how weighted averages of potential financial outcomes are derived.
  - <b>Limitations Assessment:</b> Discusses the limitations of the analysis, including assumptions made regarding unfavorable market demand for certain strategies and the inherent simplification of real-world complexities by the decision tree model.
  - <b>Strategic Recommendation:</b> Provides a primary and backup course of action based on the calculated expected values, recommending the modification of the existing drug line as the optimal strategy.

<h3>REPORTING</h3>

<h3></h3>
<b>ANALYSIS OUTPUT AND CALCULATIONS</b>
<h3></h3>

<h3>Implications & Recommendations</h3>
